Long-term prognosis of mild functional tricuspid regurgitation after mitral valve replacement

KILIÇKESMEZ, Kadriye; KÜÇÜKOĞLU, Serdar; İNCE, Nurhan; HATEMİ, Ali Can; GÜRSOY, Mete; BAKUY, Vedat; BULUT, Gülsüm

Long-term prognosis of mild functional tricuspid regurgitation after mitral valve replacement

Mete GÜRSOY, (SB Bakırköy Dr. Sadi Konuk Eğitim ve Araştırma Hastanesi, Kalp ve Damar Cerrahisi Kliniği, İstanbul, Türkiye)

Vedat BAKUY, (SB Bakırköy Dr. Sadi Konuk Eğitim ve Araştırma Hastanesi, Kalp ve Damar Cerrahisi Kliniği, İstanbul, Türkiye)

Ali Can HATEMİ, (İstanbul Üniversitesi, İstanbul Tıp Fakültesi, Kardiyovasküler Cerrahi Anabilim Dalı, İstanbul, Türkiye)

Gülsüm BULUT, (İstanbul Üniversitesi, Tıp Fakültesi, Kardiyoloji Enstitüsü, İstanbul, Türkiye)

Kadriye KILIÇKESMEZ, (İstanbul Üniversitesi, Tıp Fakültesi, Kardiyoloji Enstitüsü, İstanbul, Türkiye)

Nurhan İNCE, (İstanbul Üniversitesi, Halk Sağlığı Anabilim Dalı, İstanbul, Türkiye)

Serdar KÜÇÜKOĞLU (İstanbul Üniversitesi, Tıp Fakültesi, Kardiyoloji Enstitüsü, İstanbul, Türkiye)

Anadolu Kardiyoloji Dergisi

2 0

Yıl: 2014 Cilt: 14 Sayı: 1 Sayfa Aralığı: 34 - 39 Metin Dili: İngilizce İndeks Tarihi: 29-07-2022

Long-term prognosis of mild functional tricuspid regurgitation after mitral valve replacement

Öz:

Objective: Functional tricuspid regurgitation (FTR) is the most common type of tricuspid insufficiency and occurs approximately in 30% of patients with mitral valve disease. The major etiologic factor in the triggering of right ventricular dilation and thus causing functional tricuspid regurgitation, is pulmonary artery hypertension secondary to mitral valve disease. We aimed to analyze long-term outcomes of patients with mild tricuspid regurgitation at the time of mitral valve replacement. Methods: Sixty-six patients with mild tricuspid insufficiency who underwent mitral valve replacement were included in this observational ret- rospective study. Mean follow-up time was 8.3±0.7 years. Patients whose tricuspid regurgitation remained unchanged or decreased following operation were enrolled to group 1 (n=32), patients whose tricuspid regurgitation increased were included to group 2 (n=34) and data were compared statistically with t-test, Mann-Whitney U, Chi-square and Fisher Exact test. Multiple regression analysis was performed to determine independent risk factors for FTR progression. Results: Preoperatively female gender (p=0.02), body surface area (p=0.04), left atrium diameter (p=0.01), functional capacity (p=0.03), right ventricle diameter (p=0.04), and left ventricle mass index (p=0.04) were found to be statistically significant between groups. In the follow-up; functional capacity, grade of tricuspid insufficiency, pulmonary artery pressure, vena contracta width (p<0.001), TAPSE (tricuspid annular plane systolic excur- sion index) (p=0.04), annulus diameter (p=0.02), right ventricle diameter (p=0.01), left ventricle mass index (p=0.05), and ejection fraction (p=0.02) were found to be statistically different between groups. In multiple logistic regression analysis; preoperative LA diameter (OR=5.05; 95% CI:1.49- 17.12; p=0.009) and female gender (OR=10.93; 95% CI:1.77-67.31; p=0.01) were found as independent risk factors for FTR progression. Conclusion: This study revealed that mild FTR might advance to moderate to severe grade in more than half of the patients in the follow-up. Thus, surgical approach to even mild FTR should be individualized based on patient’s risk assessment.

Anahtar Kelime:

Konular: Kalp ve Kalp Damar Sistemi

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık

1. Demirbağ R. Management of the tricuspid valve regurgitation. Anadolu Kardiyol Derg 2009; 9 Suppl 1: 43-9.
2. Matsunaga A, Duran CM. Progression of tricuspid regurgitation after repaired functional ischemic mitral regurgitation. Circulation 2005; 112(9 Suppl): I453-7.
3. Chan V, Burwash IG, Lam BK, Auyeung T, Tran A, Mesana TG, et al. Clinical and echocardiographic impact of functional tricuspid regurgitation repair at the time of mitral valve replacement. Ann Thorac Surg 2009; 88: 1209-15. [CrossRef]
4. Sagie A, Freitas N, Chen MH, Marshall JE, Weyman AE, Levine RA. Echocardiographic assessment of mitral stenosis and its associated valvular lesions in 205 patients and lack of association with mitral valve prolapse. J Am Soc Echocardiogr 1997; 10: 141-8. [CrossRef]
5. De Bonis M, Lapenna E, Sorrentino F, La Canna G, Grimaldi A, Maisano F, et al. Evolution of tricuspid regurgitation after mitral valve repair for functional mitral regurgitation in dilated cardiomyopathy. Eur J Cardiothorac Surg 2008; 33: 600-6. [CrossRef]
6. Shiran A, Sagie A. Tricuspid regurgitation in mitral valve disease incidence, prognostic implications, mechanism, and management. J Am Coll Cardiol 2009; 53: 401-8. [CrossRef]
7. Dreyfus GD, Corbi PJ, Chan KM, Bahrami T. Secondary tricuspid regurgitation or dilatation: which should be the criteria for surgical repair? Ann Thorac Surg 2005; 79: 127-32. [CrossRef]
8. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989; 2: 358-67.
9. Schiller NB. Two-dimensional echocardiographic determination of left ventricular volume, systolic function, and mass. Summary and discussion of the 1989 recommendations of the American Society of Echocardiography. Circulation 1991; 84: 280-7.
10. Braunwald NS, Ross J Jr, Morrow AG. Conservative management of tricuspid regurgitation in patients undergoing mitral valve replacement. Circulation 1967; 35(4 suppl): I63-9.
11. Carpentier A, Deloche A, Hanania G, Forman J, Sellier P Piwnica A, et al. Surgical management of acquired tricuspid valve disease. J Thorac Cardiovasc Surg 1974; 67: 53-65.
12. The Society of Thoracic Surgeons Adult Cardiac Surgery Database Spring 2010 Report. Available at http://www.sts.org/documents/ pdf/ndb2010/1stHarvest Executive Summary%5B1%5D.pdf. Accessed August 14, 2010.
13. Song H, Kang DH, Kim JH, Park KM, Song JM, Choi KJ, et al. Percutaneous mitral valvuloplasty versus surgical treatment in mitral stenosis with severe tricuspid regurgitation. Circulation 2007; 116(11 Suppl): I246-50.
14. Boyacı A, Gökçe V, Topaloğlu S, Korkmaz S, Göksel S. Outcome of significant functional tricuspid regurgitation late after mitral valve replacement for predominant rheumatic mitral stenosis. Angiology 2007; 58: 336-42. [CrossRef]
15. Naqshband MS, Abid AR, Akhtar RP Waheed A, Khan JS. Functional tricuspid regurgitation in rheumatic heart disease: surgical options. Ann Thorac Cardiovasc Surg 2010; 16: 417-25.
16. Walls MC, Cimino N, Bolling SF, Bach DS. Persistent pulmonary hypertension after mitral valve surgery: does surgical procedure affect outcome? J Heart Valve Dis 2008; 17: 1-9.
17. Goldstone AB, Chikwe J, Pinney SP Anyanwu AC, Funt SA, Polanco A, et al. Incidence, epidemiology, and prognosis of residual pulmonary hypertension after mitral valve repair for degenerative mitral regurgitation. Am J Cardiol 2011; 107: 755-60. [CrossRef]
18. Tuğcu A, Köse O, Yıldırımtürk O, Tayyareci Y, Aytekin S. The frequency of prosthesis-patient mismatch after mechanical mitral valve replacement and its effect on postoperative systolic pulmonary arterial pressure. Turk Kardiyol Dern Ars 2009; 37: 523-30.
19. Jamieson WR, Germann E, Ye J, Chan F, Cheung A, MacNab JS, et al. Effect of prosthesis-patient mismatch on long-term survival with mitral valve replacement: assessment to 15 years. Ann Thorac Surg 2009; 87: 1135-41; discussion 1142. [CrossRef]
20. Lam BK, Chan V, Hendry P Ruel M, Masters R, Bedard P et al. The impact of patient-prosthesis mismatch on late outcomes after mitral valve replacement. J Thorac Cardiovasc Surg 2007; 133: 1464-73. [CrossRef]
21. Groves PH, Lewis NP Ikram S, Maire R, Hall RJ. Reduced exercise capacity in patients with tricuspid regurgitation after successful mitral valve replacement for rheumatic mitral valve disease. Br Heart J 1991; 66: 295-301. [CrossRef]
22. Ruel M, Rubens FD, Masters RG, Pipe AL, Bédard P Mesana TG. Late incidence and predictors of persistent or recurrent heart failure in patients with mitral prosthetic valves. J Thorac Cardiovasc Surg 2004; 128: 278-83. [CrossRef]
23. Kim HK, Kim YJ, Kim KI, Jo SH, Kim KB, Ahn H, et al. Impact of the maze operation combined with left-sided valve surgery on the change in tricuspid regurgitation over time. Circulation 2005; 112(9 Suppl): I14-9.
24. Henry WL, Morganroth J, Pearlman AS, Clark CE, Redwood DR, Itscoitz SB, et al. Relation between echocardiographically determined left atrial size and atrial fibrillation. Circulation 1976; 53: 273-9. [CrossRef]
25. Sanfilippo AJ, Abascal VM, Sheehan M, Oertel LB, Harrigan P Hughes RA, et al. Atrial enlargement as a consequence of atrial fibrillation: a prospective echocardiographic study. Circulation 1990; 82: 792-7. [CrossRef]
26. Vaturi M, Sagie A, Shapira Y, Feldman A, Fink N, Strasberg B, et al. Impact of atrial fibrillation on clinical status, atrial size and hemodynamics in patients after mitral valve replacement. J Heart Valve Dis 2001; 10: 763-6
27. Stulak JM, Schaff HV, Dearani JA, Orszulak TA, Daly RC, Sundt TM 3rd. Restoration of sinus rhythm by the Maze procedure halts progression of tricuspid regurgitation after mitral surgery. Ann Thorac Surg 2008; 86: 40-4. [CrossRef]
28. Kwak JJ, Kim YJ, Kim MK, Kim HK, Park JS, Kim KH, et al. Development of tricuspid regurgitation late after left-sided valve surgery: a single-center experience with long-term echocardiographic examinations. Am Heart J 2008; 155: 732-7. [CrossRef]
29. Wang G, Sun Z, Xia J, Deng Y, Chen J, Su G, et al. Predictors of secondary tricuspid regurgitation after left-sided valve replacement. Surg Today 2008; 38: 778-83. [CrossRef]
30. Varadarajan P Pai RG. Tricuspid regurgitation in patients with severe mitral regurgitation and normal left ventricular ejection fraction: risk factors and prognostic implications in a cohort of 895 patients. J Heart Valve Dis 2010; 19: 412-9.
31. Özben B, Başaran Y. Echocardiography and other imaging modalities in pulmonary arterial hypertension. Anadolu Kardiyol Derg 2010; 10 Suppl 1: 27-35. [CrossRef]
32. Tei C. New non-invasive index for combined systolic and diastolic ventricular function. J Cardiol 1995; 26: 135-6.
33. Smid M, Cech J, Rokyta R, Roucka P Hájek T. Mild to moderate functional tricuspid regurgitation: retrospective comparison of surgical and conservative treatment. Cardiol Res Pract 2010; 2010. pii: 143878.

APA	GÜRSOY M, BAKUY V, HATEMİ A, BULUT G, KILIÇKESMEZ K, İNCE N, KÜÇÜKOĞLU S (2014). Long-term prognosis of mild functional tricuspid regurgitation after mitral valve replacement. , 34 - 39.
Chicago	GÜRSOY Mete,BAKUY Vedat,HATEMİ Ali Can,BULUT Gülsüm,KILIÇKESMEZ Kadriye,İNCE Nurhan,KÜÇÜKOĞLU Serdar Long-term prognosis of mild functional tricuspid regurgitation after mitral valve replacement. (2014): 34 - 39.
MLA	GÜRSOY Mete,BAKUY Vedat,HATEMİ Ali Can,BULUT Gülsüm,KILIÇKESMEZ Kadriye,İNCE Nurhan,KÜÇÜKOĞLU Serdar Long-term prognosis of mild functional tricuspid regurgitation after mitral valve replacement. , 2014, ss.34 - 39.
AMA	GÜRSOY M,BAKUY V,HATEMİ A,BULUT G,KILIÇKESMEZ K,İNCE N,KÜÇÜKOĞLU S Long-term prognosis of mild functional tricuspid regurgitation after mitral valve replacement. . 2014; 34 - 39.
Vancouver	GÜRSOY M,BAKUY V,HATEMİ A,BULUT G,KILIÇKESMEZ K,İNCE N,KÜÇÜKOĞLU S Long-term prognosis of mild functional tricuspid regurgitation after mitral valve replacement. . 2014; 34 - 39.
IEEE	GÜRSOY M,BAKUY V,HATEMİ A,BULUT G,KILIÇKESMEZ K,İNCE N,KÜÇÜKOĞLU S "Long-term prognosis of mild functional tricuspid regurgitation after mitral valve replacement." , ss.34 - 39, 2014.
ISNAD	GÜRSOY, Mete vd. "Long-term prognosis of mild functional tricuspid regurgitation after mitral valve replacement". (2014), 34-39.

APA	GÜRSOY M, BAKUY V, HATEMİ A, BULUT G, KILIÇKESMEZ K, İNCE N, KÜÇÜKOĞLU S (2014). Long-term prognosis of mild functional tricuspid regurgitation after mitral valve replacement. Anadolu Kardiyoloji Dergisi, 14(1), 34 - 39.
Chicago	GÜRSOY Mete,BAKUY Vedat,HATEMİ Ali Can,BULUT Gülsüm,KILIÇKESMEZ Kadriye,İNCE Nurhan,KÜÇÜKOĞLU Serdar Long-term prognosis of mild functional tricuspid regurgitation after mitral valve replacement. Anadolu Kardiyoloji Dergisi 14, no.1 (2014): 34 - 39.
MLA	GÜRSOY Mete,BAKUY Vedat,HATEMİ Ali Can,BULUT Gülsüm,KILIÇKESMEZ Kadriye,İNCE Nurhan,KÜÇÜKOĞLU Serdar Long-term prognosis of mild functional tricuspid regurgitation after mitral valve replacement. Anadolu Kardiyoloji Dergisi, vol.14, no.1, 2014, ss.34 - 39.
AMA	GÜRSOY M,BAKUY V,HATEMİ A,BULUT G,KILIÇKESMEZ K,İNCE N,KÜÇÜKOĞLU S Long-term prognosis of mild functional tricuspid regurgitation after mitral valve replacement. Anadolu Kardiyoloji Dergisi. 2014; 14(1): 34 - 39.
Vancouver	GÜRSOY M,BAKUY V,HATEMİ A,BULUT G,KILIÇKESMEZ K,İNCE N,KÜÇÜKOĞLU S Long-term prognosis of mild functional tricuspid regurgitation after mitral valve replacement. Anadolu Kardiyoloji Dergisi. 2014; 14(1): 34 - 39.
IEEE	GÜRSOY M,BAKUY V,HATEMİ A,BULUT G,KILIÇKESMEZ K,İNCE N,KÜÇÜKOĞLU S "Long-term prognosis of mild functional tricuspid regurgitation after mitral valve replacement." Anadolu Kardiyoloji Dergisi, 14, ss.34 - 39, 2014.
ISNAD	GÜRSOY, Mete vd. "Long-term prognosis of mild functional tricuspid regurgitation after mitral valve replacement". Anadolu Kardiyoloji Dergisi 14/1 (2014), 34-39.